Friday, November 15, 2024

Day One
7:00-7:15 AM

Welcome: MGB Leadership
Keith Lillemoe, MD; Mark Varvares, MD, FACS; Gerard Doherty, MD

Welcome: Course Directors
Carrie Cunningham, MD, MPH; Marika Russell, MD, FACS; Greg Randolph, MD, FACS, FACE

7:15-7:35 AM

Lecture 1: The Thyroid Nodule in 2024
Gilbert Daniels, MD

7:35-7:55 AM

Lecture 2: Updates in mPTC
Douglas Ross, MD

7:55-8:15 AM

Lecture 3: ATA Nodules Guidelines Tour - What the Clinician Needs to Know
Lisa Orloff, MD FACS FACE

8:15-8:55 AM

Lecture 4: Kocher Lecture: What Does a Surgeon Think?
Rich Wong, MD, FACS

8:55-9:20 AM

Break

9:20-10:00 AM

Lecture 5: Preop Surgical Evaluation for PTC Hemithyroidectomy
Victoria Banuchi, MD

10:00-10:20 AM

Lecture 6: Low-Risk DTC – Follow Up After Hemithyroidectomy
Nikolaos Stathatos, MD

10:20-10:40 AM

Lecture 7: Poorly Differentiated Thyroid Cancer – Contemporary Definitions and Management
Sarimar Agosto-Salgado, MD

10:40-11:00 AM

Lecture 8: ESES Advanced Thyroid Cancer Guidelines
Marcin Barczynski, MD, PhD, FEBS-ES

11:00-11:20 AM

Lecture 9: Genetic Data and Designing Clinical Trials
Mabel Ryder, MD

11:20-11:40 AM

Lecture 10: ATA Anaplastic Guidelines Tour - What the Clinician Needs to Know
Jen Choe, MD, PhD

11:40 AM-12:25 PM

Panel #1 Thyroid Nodules – Treatment Decisions and Q&A
Moderators: Marika Russell, MD; Carrie Cunningham, MD, MPH; Nancy Cho, MD
Faculty: Runhoa Hou, MD; Erik Alexander, MD; Rajshri Gartland, MD, MPH; Mary Elizabeth Cunnane, MD; Natalia Kyriazidis, MD and Michael Otremba, MD

12:25-1:25 PM

Lunch Break

1:25-1:45 PM

Lecture 11: RLN Management in Invasive Thyroid Cancer
Dana Hartl, MD, PhD

1:45-2:05 PM

Lecture 12: BRAF-altered ATC Treatment
Mark Zafereo, MD, FACS

2:05-2:25 PM

Lecture 13: Updates on Redifferentiation Therapy in Thyroid Cancer
Laura Boucai, MD

2:25-2:45 PM

Lecture 14: Oncytic Cell Carcinoma – Genetics  and Management
Lindsay Bischoff, MD

2:45-3:05 PM

Coffee Break

3:05-3:25 PM

Lecture 15: ITOG Acquired Resistance Registry
Rory Clifton-Bligh, BSC (med), MB BS (hons), FRACP, PhD, FFSc (RCPA)

3:25-3:45 PM

Lecture 16: WHO Updates in Pathology
Adam Fisch, MD, PhD

3:45-4:05 PM

Lecture 17: RET-altered Cancer Treatment
Lori Wirth, MD

4:05-4:25 PM

Lecture 18: Avoiding Complications in Neck Dissection and Approach to the Retropharynx
Derrick Lin, MD, FACS

4:25-4:45 PM

Lecture 19: Neoadjuvant Therapy for Advanced Disease
Greg Randolph, MD, FACS, FACE

4:45-5:05 PM

Lecture 20: Tailoring Long-Term Surveillance to Extent of Surgical Treatment
Megan Haymart, MD

5:05-5:50 PM

Panel #2: Thyroid Cancer Tumor Board and Q&A
Moderators: Greg Randolph, MD, FACS, FACE; Carrie Cunningham, MD, MPH; Eleni Rettig, MD, FACS
Faculty: Lori Wirth, MD; Hien Tierney, MD; Sareh Parangi, MD; Adam Fisch, MD, PhD; Sarimar Agosto-Salgado, MD; Theodora Pappa, MD, PhD; Rich Wong, MD, FACS; Megan Haymart, MD

Saturday, November 16, 2024

Day Two
6:55-7:00 AM

Course Introduction
Carrie Cunningham, MD, MPH; Marika Russell, MD; Greg Randolph, MD, FACS, FACE

7:00-7:20 AM

Lecture 1: A Surgeon's Journey
Mark Varvares MD, FACS
 

7:20-7:40 AM

Lecture 2: Ablation of Thyroid Nodules and Cancer
Julia Noel, MD RF

7:40-8:00 AM

Lecture 3: Update in Pediatric Thyroid Cancer
Jonathan Wasserman, MD

8:00-8:20 AM

Lecture 4: What is Adult Complex Thyroid Surgery Focused Practice Designation?
Brian Nussenbaum, MD

8:20-8:40 AM

Lecture 5: Graves Ophthalmopathy 2024
Suzanne Freitag, MD

8:40-9:20 AM

Lecture 6: Cope Lecture: Surgery for Graves
Richard Hodin, MD

9:20-9:40 AM

Break

9:40-10:00 AM

Lecture 7: Practical Office US 2024 - Pearls From a Busy Practice
Giuseppe Barbesino, MD

10:00-10:20 AM

Lecture 8: Disparities in Access to Thyroid Care
Louise Davies, MD, MS

10:20-10:40 AM

Lecture 9: NCCN Thyroid Cancer Framework Guidelines
Robert Haddad, MD

10:40 AM-11:00 AM

Lecture 10: Financial Burden of Thyroid Cancer
Carrie Cunningham, MD, MPH

11:00-11:20 AM

Lecture 11: How Can We Be the Best Surgical Educator?
Roy Phitayakorn, MD, MHPE, MAMSE, FACS

11:20 AM-12:05 PM

Thyroid Ablation 3-Way Debate – What Is the Best Ablative Technology in 2024?

RFA  (10 min)- Roberto Valcavi, MD
Microwave (10 min)- Shuhang Xu, MD
Laser (10 min)- Roberto Negro, MD
5 min Moderated Q&A: Julia Noel, MD, FACS; Marika Russell, MD

12:05-1:05 PM

Lunch Break

1:05-1:25 PM

Lecture 12: Autofluorescence and Parathyroid Vascular Assessment
Frédéric Triponez, MD

1:25-1:45 PM

Lecture 13: HPT Imaging: 4D CT
Hillary Kelly, MD

1:45-2:05 PM

Lecture 14: Essentials of Preop HPT Evaluation– a Surgeon’s Perspective
David Shonka, MD

2:05-2:25 PM

Lecture 15: Long Acting PTH Treatment for Hypoparathyroidism -Palopegteriparatide (TransconPTH) and Eneboparatide (AZP-3601)  - 2024
Michael Mannstadt, MD

2:25-2:45 PM

Lecture 16:  When Should you Operate? Update on Indications for Parathyroidectomy - the 5th International Workshop - Summary Statement and Guidelines
Shonni Silverberg, MD

2:45-3:15 PM

Coffee Break

3:15-3:35 PM

Lecture 17: 2nd HPT Surgery: When and How Much?
Peter Angelos, MD, PhD

3:35-3:55 PM

Lecture 18: Normocalemic and Normohormonal HPT
Michael Singer, MD, FACS, FACE

3:55-4:35 PM

Panel #1: Parathyroid Panel
Moderators: Antonia Stephen, MD; Peter Angelos, MD, PhD; Gerard Doherty, MD
Faculty: Leslie Eldeiry, MD; Michael Singer, MD, FACS, FACE; David Shonka, MD; Richard Hodin, MD; Shonni Silverberg, MD

4:35-4:45 PM

Closing Remarks/Adjourn
Carrie Cunningham, MD, MPH; Marika Russell, MD; Greg Randolph, MD, FACS, FACE